Dehydrojuncusol
Dehydrojuncusol, a potent HCV inhibitor, targets HCV NS5A and is able to inhibit RNA replication of replicons harboring resistance mutations to anti-NS5A direct-acting antivirals. Dehydrojuncusol significantly inhibits HCV infection when added after virus inoculation of HCV genotype 2a (EC50=1.35 μM) [1].
Product Specifications
CAS Number
117824-04-1
UNSPSC
12352005
Target
HCV; HCV Protease
Type
Natural Products
Related Pathways
Anti-infection; Metabolic Enzyme/Protease
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/dehydrojuncusol.html
Solubility
10 mM in DMSO
Smiles
OC1=CC=C2C3=C(C=C)C(C)=C(O)C=C3C=CC2=C1C
Molecular Formula
C18H16O2
Molecular Weight
264.32
References & Citations
[1]Sahuc ME, et al. Dehydrojuncusol, a Natural Phenanthrene Compound Extracted from Juncus maritimus, Is a New Inhibitor of Hepatitis C Virus RNA Replication. J Virol. 2019;93 (10) :e02009-18. Published 2019 May 1.
Shipping Conditions
Room temperature
Scientific Category
Natural Products
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
B2068 96 Tests
Acetylcholine Receptor subunit gamma (CHRNG) Chicken ELISA Kit
Sign In for Pricing
View Details 
377683-01 10 µg
ACP5, Recombinant, Human, aa22-325 (Tartrate-resistant Acid Phosphatase Type 5, SPENCDI, TRAP, HPAP, TRACP5a, TRACP5b, TrATPase)
Sign In for Pricing
View Details 377683-02 50 µg
ACP5, Recombinant, Human, aa22-325 (Tartrate-resistant Acid Phosphatase Type 5, SPENCDI, TRAP, HPAP, TRACP5a, TRACP5b, TrATPase)
Sign In for Pricing
View Details 